SEC Form 4 · accession 0001209191-17-065249

Denali Therapeutics Inc. · DNLI

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Director

Period of report

Dec 12, 2017

Accepted (ET)

Dec 12, 2017 · 5:43 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001714899

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1,F2	Dec 12, 2017	C	105,225	—	A	105,225	I	See footnote
Common Stock^F1,F3	Dec 12, 2017	C	19,774	—	A	19,774	I	See footnote
Common Stock^F1,F4	Dec 12, 2017	C	105,225	—	A	105,225	I	See footnote
Common Stock^F1,F5	Dec 12, 2017	C	19,774	—	A	19,774	I	See footnote
Common Stock	holding	—	—		—	75,000	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	D/I
Series A-1 Preferred Stock^F2,F1	—	Dec 12, 2017	C	105,225	D	—	—	Common Stock	105,225	I
Series A-1 Preferred Stock^F3,F1	—	Dec 12, 2017	C	19,774	D	—	—	Common Stock	19,774	I
Series A-1 Preferred Stock^F4,F1	—	Dec 12, 2017	C	105,225	D	—	—	Common Stock	105,225	I
Series A-1 Preferred Stock^F5,F1	—	Dec 12, 2017	C	19,774	D	—	—	Common Stock	19,774	I

F1The Series A-1 Preferred Stock automatically converted into shares of Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date.
F2The shares are held of record by the David P. Schenkein 2015 Denali Qualified Annuity Trust, for which the Reporting Person serves as a trustee.
F3The shares are held of record by the David P. Schenkein 2004 Revocable Trust, for which the Reporting Person serves as a trustee.
F4The shares are held of record by the Amy P. Schenkein 2015 Denali Qualified Annuity Trust, for which the Reporting Person serves as a trustee.
F5The shares are held of record by the Amy P. Schenkein 2004 Revocable Trust, for which the Reporting Person serves as a trustee.